S022 Alopecia Areata: New Therapies
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
With the current interest in hair loss conditions being on the rise, it is important to understand alopecia areata as it is the most common cause of immune- mediated alopecia, affecting 2% of the USA population. The intricate pathology, patients demographics and comorbidities, and the new therapeutic options will be discussed. The team of speakers have been leaders in developing alopecia areata severity scale and therapeutic guidelines.
LEARNING OBJECTIVES
Compare and analyze novel therapies for alopecia areata
Identify patients who are eligible for novel medications considering their comorbidities
Describe therapeutic guidelines for alopecia areata, including dosing, duration of treatment and clinical prognosis
SCHEDULE
9:00 PM
Current state of alopecia areata
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
9:10 PM
Alopecia areata: diagnostic pearls
Chesahna Kindred, MD, MBA, FAAD
9:30 PM
Adults with Alopecia Areata: My treatment approach
Maryanne Makredes Senna, MD, FAAD
9:50 PM
The World of JAK inhibitors
Brett Andrew King, MD, PhD, FAAD
10:10 PM
How to treat children with Alopecia areata?
Brittany Gareth Craiglow, MD, FAAD
10:30 PM
Do I use any procedures for areata treatment?
Jerry Shapiro, MD, FAAD
10:45 PM
Burning QUESTIONS
11:00 PM
My Top 3 Pearls for Alopecia Areata
Wilma Fowler Bergfeld, MD, FAAD
11:15 PM
Dermoscopy Tips to Recognize Areata
Bruna Duque-Estrada, MD
11:25 PM
AA therapy: Global Perspective
Rodrigo Pirmez, MD
11:40 PM
JAK inhibitors and Young women
Tina Bhutani, MD, FAAD
11:55 PM
LAST QUESTIONS
SPEAKERS
Wilma Fowler Bergfeld, MD, FAAD
Tina Bhutani, MD, FAAD
Brittany Gareth Craiglow, MD, FAAD
Bruna Duque-Estrada, MD
Chesahna Kindred, MD, MBA, FAAD
Brett Andrew King, MD, PhD, FAAD
Maryanne Makredes Senna, MD, FAAD
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
Rodrigo Pirmez, MD
Jerry Shapiro, MD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Wilma Fowler Bergfeld, MD, FAAD
No financial relationships exist with ineligible companies.
Tina Bhutani, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Amgen – Speaker(Honoraria); Arcutis Biotherapeutics – Speaker(Honoraria); Arcutis, Inc. – Advisory Board(Fees); ASLAN Pharmaceuticals – Data Safety Monitoring Board(Fees); Boehringer Ingelheim – Advisory Board(Fees); Bristol-Myers Squibb – Advisory Board(Fees); Castle Biosciences – Investigator(Grants/Research Funding); Celgene – Investigator(Grants/Research Funding); Clementia Pharmaceuticals – Investigator(Grants/Research Funding); CoreEvitas, LLC – Investigator(Grants/Research Funding); Dermatology Foundation – Speaker(Honoraria); Dermavant Sciences – Investigator(Grants/Research Funding); Eli Lilly – Speaker(Honoraria); Eli Lilly and Company – Advisory Board(Fees); FIDE – Consultant(Fees); Galderma – Speaker(Honoraria); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding); Happify – Consultant(Fees); Janssen Biotech – Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Fees); Janssen Research & Development, LLC – Investigator(Grants/Research Funding); LearnSkin – Speaker(Honoraria); LEO Pharma, US – Advisory Board(Fees); Mindera – Investigator(Grants/Research Funding); National Psoriasis Foundation – Speaker(Honoraria); Novartis – Advisory Board(Fees), Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Consultant(Fees); UCB – Advisory Board(Fees);
Brittany Gareth Craiglow, MD, FAAD
AbbVie – Speaker(Honoraria); Concert Pharmaceuticals – Consultant(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Fees), Advisory Board(Honoraria), Consultant(Fees), Speaker(Honoraria); EltaMD – Other(Honoraria); Incyte Corporation – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Fees), Advisory Board(Honoraria), Consultant(Fees), Investigator(No Compensation Received), Speaker(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Fees), Speaker(Honoraria); Roivant Sciences – Consultant(Fees); Sanofi Genzyme – Speaker(Honoraria);
Bruna Duque-Estrada, MD
No financial relationships exist with ineligible companies.
Chesahna Kindred, MD, MBA, FAAD
AbbVie – Consultant (1099 relationship)(Fees), Speaker(Fees); Aerolase – Speaker(Fees); Eli Lilly – Investigator(Fees); Factor Medical – Speaker(Fees); Lilly ICOS LLC – Advisory Board(Fees), Speaker/Faculty Education(Fees); Novartis Pharmaceuticals Corp. – Advisory Board(Fees); Nutrafol – Speaker/Faculty Education(Fees); Pfizer Inc. – Speaker/Faculty Education(Fees); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees); UCB – Advisory Board(Fees);
Brett Andrew King, MD, PhD, FAAD
AbbVie – Advisory Board(Honoraria), Speaker(Honoraria); AnaptysBio – Consultant(Fees), Investigator(Fees); Arena Pharmaceuticals – Consultant(Fees), Investigator(Fees); ASLAN Pharmaceuticals – Consultant (1099 relationship)(Fees), Investigator(Fees); BiologicsMD, Inc. – Consultant(Stock Options); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees), Data Safety Monitoring Board(Fees); Concert Pharmaceuticals – Consultant(Fees), Investigator(Fees); Eli Lilly and Company – Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Equillium, Inc. – Consultant(Fees); Horizon Pharma, Inc. – Consultant(Fees); Incyte Corporation – Advisory Board(Honoraria), Consultant(Fees), Data Safety Monitoring Board(Fees), Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Consultant(Fees); Pfizer Inc. – Advisory Board(Fees), Advisory Board(Honoraria), Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Q32 Bio Inc. – Consultant (1099 relationship)(Fees), Investigator(Fees); Regeneron – Speaker(Honoraria); Sanofi Genzyme – Speaker(Honoraria); TWi Biotechnology, Inc. – Consultant(Fees);
Maryanne Makredes Senna, MD, FAAD
AbbVie – Advisory Board(Fees); American Hair Research Society – Board of Directors(No Compensation Received); Arena Pharmaceuticals – Advisory Board(Fees); Cassiopia – Advisory Board(Fees); Cicatricial Alopecia Research Foundation – Board of Directors(No Compensation Received); Concert Pharmaceuticals – Consultant(Fees); Department Of Health and Human Services; Division of Vaccine Injury Compensation – Independent Contractor(Fees); Eli Lilly – Speaker(Fees); Eli Lilly and Company – Advisory Board(Fees), Investigator(Grants/Research Funding); Follica – Investigator(Equipment); Inmagene Biopharmaceuticals – Consultant (1099 relationship)(Fees); Kintor Pharmaceutical Limited – Consultant (1099 relationship)(Fees); L'Oreal USA Inc. – Consultant (1099 relationship)(Fees); Leo Pharma Inc – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Fees), Other(Grants/Research Funding), Speaker(Fees); Santiste Medical – Investigator(Grants/Research Funding);
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
AbbVie – Investigator(No Compensation Received); Arcutis, Inc. – Investigator(No Compensation Received); Arena Pharmaceuticals – Advisory Board(Honoraria), Investigator(No Compensation Received); Concert Pharmaceuticals – Advisory Board(Honoraria); Eli Lilly – Speaker(Honoraria); Kyowa Hakko Kirin Pharma, Inc. – Investigator(No Compensation Received); La Roche-Posay Laboratorie Pharmaceutique – Advisory Board(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Investigator(No Compensation Received); Merz Aesthetics – Investigator(Grants/Research Funding); Nutrafol – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Rodrigo Pirmez, MD
Ache Laboratório Farmaceuticso S.A. – Consultant(Fees); Darrow – Consultant(Fees); Eli Lilly and Company – Consultant(Fees); GlaxoSmithKline Immunology – Speaker(Fees); Pfizer Inc. – Consultant(Fees); Vichy Laboratoires – Speaker(Fees);
Jerry Shapiro, MD, FAAD
30 Madison – Consultant (1099 relationship)(Stock Options); Almirall – Consultant (1099 relationship)(Honoraria); Eli Lilly – Advisory Board(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Honoraria);